EDITORIAL
Inhibición de la proproteína convertasa subtilisina/kexina tipo 9 en el tratamiento de la hipercolesterolemia
Inhibition of proprotein convertase subtilisin/kexin type 9 in the treatment of hypercholesterolemia
Juan F. Ascaso
Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, departamento de Medicina, Universitat de Valencia, INCLIVA, CIBERDEM, presidente de la Sociedad Española de Arteriosclerosis
Leído
11941
Vecesse ha leído el artículo
1692
Total PDF
10249
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 28 | 4 | 32 |
| 2025 11 | 108 | 31 | 139 |
| 2025 10 | 93 | 17 | 110 |
| 2025 9 | 90 | 7 | 97 |
| 2025 8 | 104 | 12 | 116 |
| 2025 7 | 99 | 9 | 108 |
| 2025 6 | 122 | 5 | 127 |
| 2025 5 | 109 | 7 | 116 |
| 2025 4 | 113 | 4 | 117 |
| 2025 3 | 137 | 8 | 145 |
| 2025 2 | 132 | 13 | 145 |
| 2025 1 | 106 | 2 | 108 |
| 2024 12 | 125 | 5 | 130 |
| 2024 11 | 123 | 10 | 133 |
| 2024 10 | 124 | 6 | 130 |
| 2024 9 | 142 | 13 | 155 |
| 2024 8 | 79 | 8 | 87 |
| 2024 7 | 114 | 7 | 121 |
| 2024 6 | 96 | 2 | 98 |
| 2024 5 | 79 | 3 | 82 |
| 2024 4 | 80 | 6 | 86 |
| 2024 3 | 82 | 14 | 96 |
| 2024 2 | 100 | 6 | 106 |
| 2024 1 | 104 | 16 | 120 |
| 2023 12 | 88 | 7 | 95 |
| 2023 11 | 196 | 15 | 211 |
| 2023 10 | 149 | 11 | 160 |
| 2023 9 | 90 | 8 | 98 |
| 2023 8 | 101 | 10 | 111 |
| 2023 7 | 69 | 10 | 79 |
| 2023 6 | 112 | 12 | 124 |
| 2023 5 | 178 | 14 | 192 |
| 2023 4 | 104 | 0 | 104 |
| 2023 3 | 113 | 10 | 123 |
| 2023 2 | 71 | 16 | 87 |
| 2022 1 | 72 | 21 | 93 |
| 2022 12 | 67 | 10 | 77 |
| 2022 11 | 150 | 14 | 164 |
| 2022 10 | 99 | 22 | 121 |
| 2022 9 | 106 | 21 | 127 |
| 2022 8 | 70 | 12 | 82 |
| 2022 7 | 40 | 16 | 56 |
| 2022 6 | 54 | 14 | 68 |
| 2022 5 | 72 | 17 | 89 |
| 2022 4 | 66 | 33 | 99 |
| 2022 3 | 60 | 11 | 71 |
| 2022 2 | 72 | 16 | 88 |
| 2021 1 | 85 | 13 | 98 |
| 2021 12 | 86 | 11 | 97 |
| 2021 11 | 79 | 21 | 100 |
| 2021 10 | 107 | 18 | 125 |
| 2021 9 | 79 | 25 | 104 |
| 2021 8 | 81 | 28 | 109 |
| 2021 7 | 46 | 19 | 65 |
| 2021 6 | 63 | 14 | 77 |
| 2021 5 | 100 | 29 | 129 |
| 2021 4 | 211 | 43 | 254 |
| 2021 3 | 109 | 20 | 129 |
| 2021 2 | 105 | 32 | 137 |
| 2020 1 | 93 | 18 | 111 |
| 2020 12 | 90 | 12 | 102 |
| 2020 11 | 92 | 5 | 97 |
| 2020 10 | 91 | 16 | 107 |
| 2020 9 | 76 | 23 | 99 |
| 2020 8 | 104 | 17 | 121 |
| 2020 7 | 70 | 21 | 91 |
| 2020 6 | 78 | 22 | 100 |
| 2020 5 | 153 | 32 | 185 |
| 2020 4 | 74 | 30 | 104 |
| 2020 3 | 79 | 26 | 105 |
| 2020 2 | 84 | 11 | 95 |
| 2020 1 | 114 | 14 | 128 |
| 2019 12 | 99 | 35 | 134 |
| 2019 11 | 107 | 19 | 126 |
| 2019 10 | 111 | 20 | 131 |
| 2019 9 | 170 | 30 | 200 |
| 2019 8 | 112 | 14 | 126 |
| 2019 7 | 101 | 27 | 128 |
| 2019 6 | 139 | 48 | 187 |
| 2019 5 | 177 | 49 | 226 |
| 2019 4 | 157 | 37 | 194 |
| 2019 3 | 94 | 21 | 115 |
| 2019 2 | 86 | 20 | 106 |
| 2019 1 | 77 | 10 | 87 |
| 2018 12 | 96 | 22 | 118 |
| 2018 11 | 125 | 25 | 150 |
| 2018 10 | 129 | 13 | 142 |
| 2018 9 | 151 | 16 | 167 |
| 2018 8 | 42 | 5 | 47 |
| 2018 7 | 32 | 2 | 34 |
| 2018 6 | 40 | 4 | 44 |
| 2018 5 | 90 | 10 | 100 |
| 2018 4 | 79 | 5 | 84 |
| 2018 3 | 45 | 0 | 45 |
| 2018 2 | 39 | 3 | 42 |
| 2018 1 | 53 | 12 | 65 |
| 2017 12 | 54 | 5 | 59 |
| 2017 11 | 97 | 7 | 104 |
| 2017 10 | 70 | 8 | 78 |
| 2017 9 | 55 | 5 | 60 |
| 2017 8 | 61 | 12 | 73 |
| 2017 7 | 58 | 5 | 63 |
| 2017 6 | 56 | 7 | 63 |
| 2017 5 | 60 | 5 | 65 |
| 2017 4 | 56 | 4 | 60 |
| 2017 3 | 50 | 36 | 86 |
| 2017 2 | 68 | 4 | 72 |
| 2016 1 | 42 | 1 | 43 |
| 2016 12 | 41 | 10 | 51 |
| 2016 11 | 4 | 1 | 5 |
| 2016 10 | 1 | 1 | 2 |
| 2016 9 | 6 | 4 | 10 |
| 2016 8 | 5 | 4 | 9 |
| 2016 7 | 9 | 4 | 13 |
| 2016 6 | 68 | 67 | 135 |
Mostrar todo
